Skip to content
OpenCapital
Get started

CONMED CNMD Free cash flow margin

Free cash flow margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp
Stryker logo
StrykerSYK
18.1%+2.7pp
Boston Scientific logo
Boston ScientificBSX
16.9%-0.3pp
Vericel logo
VericelVCEL
16.3%—
OSI Systems logo
OSI SystemsOSIS
4%+1.5pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
17.3%-1.6pp

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Calculated from CONMED’s reported figures.

free cash flow/total revenue=9%

Based on trailing twelve months.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's free cash flow margin?
CONMED (CNMD) reported free cash flow margin of 9% in Q1 2026.
How has CONMED's free cash flow margin changed year-over-year?
CONMED's free cash flow margin decreased by 27.8% year-over-year, from 12.5% to 9%.
What is the long-term trend for CONMED's free cash flow margin?
Over 4 years (2020 to 2025), CONMED's free cash flow margin has grown at a 16.4% compound annual growth rate (CAGR), from 6% to 11%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.